Published in J Virol on November 01, 1996
Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev (1997) 2.53
Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J Virol (2000) 1.36
Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J Neurovirol (2005) 1.27
Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells. J Virol (1997) 0.99
Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J Virol (1999) 0.94
Cultured vestibular ganglion neurons demonstrate latent HSV1 reactivation. Laryngoscope (2011) 0.84
A Herpesviral Lytic Protein Regulates the Structure of Latent Viral Chromatin. MBio (2016) 0.80
Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line. J Virol (2002) 0.78
Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy. Oncolytic Virother (2015) 0.76
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 21.15
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A (1976) 21.06
A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene (1988) 8.40
A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell (1993) 6.13
The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron (1990) 5.19
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol (1989) 4.85
Sodium butyrate inhibits histone deacetylation in cultured cells. Cell (1978) 4.20
Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology (1979) 4.02
Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A (1991) 3.87
Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell (1994) 3.70
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol (1992) 3.56
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1995) 3.18
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88
Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J Virol (1990) 2.87
The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc Natl Acad Sci U S A (1991) 2.47
Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol Cell Biol (1990) 2.42
A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J Virol (1993) 2.28
Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J Gen Virol (1990) 2.25
Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol (1987) 2.01
In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J Gen Virol (1993) 1.93
Activation of latent herpes simplex by trigeminal sensory-root section. N Engl J Med (1952) 1.93
The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology (1992) 1.89
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. J Virol (1990) 1.85
Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology (1992) 1.81
Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol (1993) 1.78
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology (1995) 1.77
Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci (1990) 1.69
The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc Natl Acad Sci U S A (1993) 1.63
Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. J Virol (1991) 1.50
Identification of a major regulatory sequence in the latency associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1). Virology (1991) 1.48
Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol (1988) 1.47
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol (1994) 1.45
The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol (1996) 1.33
A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol Cell Biol (1993) 1.28
Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest Ophthalmol Vis Sci (1992) 1.23
Localization of cis-acting sequence requirements in the promoter of the latency-associated transcript of herpes simplex virus type 1 required for cell-type-specific activity. J Virol (1992) 1.13
Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region. J Virol (1993) 1.11
Regulation of the rat metallothionein-I gene by sodium butyrate. Nucleic Acids Res (1986) 1.09
Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line. Virology (1991) 1.06
Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses. Proc Natl Acad Sci U S A (1993) 1.06
Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells. Arch Virol (1989) 1.06
Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology (1994) 1.05
Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Virology (1989) 1.05
Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release. J Virol (1994) 1.00
n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses. J Virol (1994) 0.98
5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol (1991) 0.96
Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. J Virol (1990) 0.95
Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells. J Biol Chem (1994) 0.92
Butyrate blocks the accumulation of CDC2 mRNA in late G1 phase but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts BP-A31. J Cell Physiol (1990) 0.92
Unusual c-fos induction upon chromaffin PC12 differentiation by sodium butyrate: loss of fos autoregulatory function. Nucleic Acids Res (1990) 0.91
Sodium butyrate activates human immunodeficiency virus long terminal repeat--directed expression. Biochem Biophys Res Commun (1987) 0.90
Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons. J Cell Biol (1993) 0.90
Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate. J Biol Chem (1987) 0.89
Transcriptional activation of the adenine phosphoribosyltransferase promoter by an upstream butyrate-induced Moloney murine sarcoma virus enhancer-promoter element. J Virol (1990) 0.87
Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice. J Gen Virol (1992) 0.86
Butyrate-induced reversal of herpes simplex virus restriction in neuroblastoma cells. Virology (1986) 0.86
Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate. Nucleic Acids Res (1992) 0.83
Proenkephalin gene expression in the PC12 pheochromocytoma cell line: stimulation by sodium butyrate. Endocrinology (1987) 0.82
Butyrate-induced changes in nuclease sensitivity of chromatin cannot be correlated with transcriptional activation. Mol Cell Biol (1987) 0.82
The roles of the cAMP-response element and TATA box in expression of the herpes simplex virus type 1 latency-associated transcripts. Virology (1995) 0.79
Early changes in protein synthesis induced by basic fibroblast growth factor, nerve growth factor, and epidermal growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci U S A (1994) 0.79
Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J Virol (1978) 11.19
Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol (1980) 9.30
Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care (1988) 9.27
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol (1985) 6.67
Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med (1987) 6.06
Anatomy of herpes simplex virus DNA. IX. Apparent exclusion of some parental DNA arrangements in the generation of intertypic (HSV-1 X HSV-2) recombinants. J Virol (1977) 5.98
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol (1987) 5.71
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature (1984) 5.53
Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology (1973) 5.10
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol (1989) 4.85
Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol Cell Biol (1985) 4.74
Quality of life measures in health care. I: Applications and issues in assessment. BMJ (1992) 4.53
A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology (1981) 4.37
DNA synthesis and DNA polymerase activity of herpes simplex virus type 1 temperature-sensitive mutants. J Virol (1975) 4.31
Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2. J Virol (1978) 4.31
Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol (1989) 4.18
Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol Cell Biol (1985) 4.14
Genetic analysis of temperature-sensitive mutants which define the gene for the major herpes simplex virus type 1 DNA-binding protein. J Virol (1983) 3.98
Temperature-sensitive mutants in herpes simplex virus type 1 ICP4 permissive for early gene expression. J Virol (1984) 3.76
Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol (1989) 3.63
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol (1993) 3.43
Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci U S A (1980) 3.32
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab (2001) 3.16
Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science (1998) 3.15
Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J Virol (1988) 3.14
Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J Gen Virol (1988) 3.11
Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J Virol (1992) 3.10
Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res (1987) 2.99
A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1997) 2.83
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol (1995) 2.82
Synthesis of virus-specific polypaptides by temperature-sensitive mutants of herpes simplex virus type 1. Virology (1976) 2.72
Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1. J Virol (1977) 2.71
Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment. Virology (1983) 2.66
Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus. J Virol (1984) 2.51
DNA sequences of two yeast promoter-up mutants. Nature (1983) 2.50
The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc Natl Acad Sci U S A (1991) 2.47
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol (1997) 2.35
Hydroxylamine mutagenesis of HSV DNA and DNA fragments: introduction of mutations into selected regions of the viral genome. Virology (1979) 2.30
Physical mapping of herpes simplex virus type 1 ts mutants by marker rescue: correlation of the physical and genetic maps. Virology (1980) 2.30
A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J Virol (1993) 2.28
Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ (1992) 2.28
A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J Virol (1991) 2.25
Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development (1991) 2.21
Genetic and phenotypic characterization of mutants in four essential genes that map to the left half of HSV-1 UL DNA. Virology (1987) 2.21
Generation of genetic diversity in herpes simplex virus: an antimutator phenotype maps to the DNA polymerase locus. Virology (1984) 2.19
Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J Virol (1995) 2.13
Recombination between temperature-sensitive mutants of herpes simplex virus type 1. Virology (1974) 2.12
Physical and genetic analysis of the herpes simplex virus DNA polymerase locus. Virology (1980) 2.11
A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology (1989) 2.10
Characterization of transposable element-associated mutations that alter yeast alcohol dehydrogenase II expression. Mol Cell Biol (1983) 2.09
Isolation, complementation and preliminary phenotypic characterization of temperature-sensitive mutants of herpes simplex virus type 2. Virology (1974) 2.04
Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J (2003) 1.99
Thymidine kinase activity of biochemically transformed mouse cells after superinfection by thymidine kinase-negative, temperature-sensitive, herpes simplex virus mutants. Virology (1978) 1.98
ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol (2001) 1.96
The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. J Immunol (1981) 1.90
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol (1986) 1.87
A requirement for ARF6 in Fcgamma receptor-mediated phagocytosis in macrophages. J Biol Chem (1998) 1.82
Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol (1998) 1.80
A temperature-sensitive mutation in a herpes simplex virus type 1 gene required for viral DNA synthesis maps to coordinates 0.609 through 0.614 in UL. J Virol (1988) 1.80
Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine. J Virol (1982) 1.79
Initial effects of the grounding of the tanker Braer on health in Shetland. The Shetland Health Study Group. BMJ (1993) 1.77
ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol (2001) 1.76
Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. J Virol (1981) 1.74
Detecting delirium among hospitalized older patients. Arch Intern Med (1995) 1.73
ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J Virol (1999) 1.73
Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J Virol (1997) 1.72
Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun (1980) 1.71
Temperature-sensitive mutants of herpes simplex virus type 1 defective in transcriptional and post-transcriptional functions required for viral DNA synthesis. Virology (1978) 1.70
Temperature-sensitive mutants of herpesviruses. Curr Top Microbiol Immunol (1975) 1.69
Expression of the syncytial (syn) phenotype in HSV-1, strain KOS: genetic and phenotypic studies of mutants in two syn loci. Virology (1981) 1.68
Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care (2001) 1.67
Lead poisoning in children of lead workers: home contamination with industrial dust. N Engl J Med (1977) 1.66
Genetic and phenotypic analysis of herpes simplex virus type 1 mutants conditionally resistant to immune cytolysis. J Virol (1983) 1.66
HIV testing on all pregnant women. Lancet (1987) 1.66
Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J Virol (1994) 1.66
Elements in the transcriptional regulatory region flanking herpes simplex virus type 1 oriS stimulate origin function. J Virol (1991) 1.66
An action plan for mouse genomics. Nat Genet (1999) 1.65
Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med (1995) 1.65
Intertypic complementation and recombination between temperature-sensitive mutants of herpes simplex virus types 1 and 2. Virology (1976) 1.65
ADR1-mediated regulation of ADH2 requires an inverted repeat sequence. Mol Cell Biol (1986) 1.57
Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin. Nucleic Acids Res (1983) 1.56
Electron microscopic studies of temperature-sensitive mutants of herpes simplex virus type 1. Virology (1974) 1.55
A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development (2001) 1.54
Expression of herpes simplex virus type 1 major DNA-binding protein, ICP8, in transformed cell lines: complementation of deletion mutants and inhibition of wild-type virus. J Virol (1987) 1.51
Herpes simplex virus type 1 oriL is not required for virus replication or for the establishment and reactivation of latent infection in mice. J Virol (1987) 1.51
Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations. Am J Hypertens (2000) 1.51
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res (1998) 1.48
Viral gene functions expressed and detected by temperature-sensitive mutants of herpes simplex virus. Cold Spring Harb Symp Quant Biol (1975) 1.48
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol (2001) 1.47
Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo. J Virol (2000) 1.45
Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4. J Virol (1994) 1.45
Thymidine kinase activity of herpes simplex virus temperature-sensitive mutants. Intervirology (1973) 1.42
Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology (2000) 1.42
The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev (1990) 1.40
Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol (1996) 1.40